• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogues.

作者信息

Sircar I, Duell B L, Cain M H, Burke S E, Bristol J A

出版信息

J Med Chem. 1986 Nov;29(11):2142-8. doi: 10.1021/jm00161a003.

DOI:10.1021/jm00161a003
PMID:3783575
Abstract

Several N-substituted 3H-indeno[1,2-c]pyridazinones (1-23) and a benzo[h]cinnolinone (24), which were designed as rigid structural modifications of 5-alkyl-4,5-dihydro-6-[4-N-substituted phenyl]-3(2H)-pyridazinones (ib-d), were synthesized and evaluated for positive inotropic activity. Most of these tricyclic pyridazinones (1-11, 14-15, 22-23) demonstrated potent positive inotropic activity comparable to the corresponding phenylpyridazinones related to I.

摘要

相似文献

1
Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogues.
J Med Chem. 1986 Nov;29(11):2142-8. doi: 10.1021/jm00161a003.
2
Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
J Med Chem. 1987 Oct;30(10):1724-8. doi: 10.1021/jm00393a007.
3
Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones.强心剂。3. 新型6-(取代的1H-咪唑-4(5)-基)-3(2H)-哒嗪酮的合成及生物活性
J Med Chem. 1986 Feb;29(2):261-7. doi: 10.1021/jm00152a015.
4
Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position.
Chem Pharm Bull (Tokyo). 1991 Feb;39(2):352-7. doi: 10.1248/cpb.39.352.
5
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
J Med Chem. 1985 Oct;28(10):1405-13. doi: 10.1021/jm00148a006.
6
Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.作为强心剂的6-苯基-4,5-二氢-3(2H)-哒嗪酮衍生物的设计、合成及构效关系研究
Arzneimittelforschung. 2008;58(11):569-73. doi: 10.1055/s-0031-1296558.
7
Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.取代苯并[h]噌啉酮和3H-苯并[6,7]环庚并[1,2-c]哒嗪酮的合成与生物学评价:抗高血压和抗血栓形成的5H-茚并[1,2-c]哒嗪酮的高级同系物
J Med Chem. 1989 Oct;32(10):2277-82. doi: 10.1021/jm00130a009.
8
Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one.二氢哒嗪酮强心剂:1,3 - 二氢 - 3,3 - 二甲基 - 5 - (1,4,5,6 - 四氢 - 6 - 氧代 - 3 - 哒嗪基)-2H - 吲哚 - 2 - 酮的发现及正性肌力活性
J Med Chem. 1986 Oct;29(10):1832-40. doi: 10.1021/jm00160a006.
9
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.强心剂。9. 一系列(E)-4,5-二氢-6-[2-[4-(1H-咪唑-1-基)苯基]乙烯基]-3(2H)-哒嗪酮的合成与生物学评价:一类用于治疗充血性心力衰竭的具有正性肌力、抗血栓形成和血管舒张活性的新型化合物。
J Med Chem. 1989 Feb;32(2):342-50. doi: 10.1021/jm00122a011.
10
A novel class of cardiotonics. Synthesis and pharmacological properties of [4-(substituted-amino)phenyl]pyridazinones and related derivatives.一类新型强心药。[4-(取代氨基)苯基]哒嗪酮及相关衍生物的合成与药理性质
J Med Chem. 1987 Jul;30(7):1157-61. doi: 10.1021/jm00390a007.

引用本文的文献

1
Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview.基于三环哒嗪酮的分子的治疗潜力:综述。
Int J Mol Sci. 2025 Apr 17;26(8):3806. doi: 10.3390/ijms26083806.
2
Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitors.药物设计的策略方法。II. 磷酸二酯酶底物和抑制剂的建模研究。
J Comput Aided Mol Des. 1987 Jul;1(2):97-119. doi: 10.1007/BF01676955.